Get ‘Back to Normal’ with The Dispatch

Check out of current events these past few months? After the year-and-a-half we’ve had, I don’t blame you. Heck, if my ability to pay my rent and fantasy football dues didn’t hinge on writing a daily morning newsletter, I probably would have gone straight to the airport after my second COVID-19 vaccine dose and flown to a remote island where none of the Washington bickering could reach me.

This isn’t to say we haven’t covered a lot of important stories in The Morning Dispatch this summer—not at all. From Supreme Court rulings to infrastructure negotiations, the Delta variant and its effect on the economic recovery to the United States’ chaoticwithdrawal from Afghanistan, I’m incredibly proud of all the work our small—but growing!—team has done. Still, if, after a year or so of being cooped up at home away from friends and family, you decided to spend the past few months enjoying life and not reading up on the United States’ cybersecurity posture vis-a-vis China, we get it.

So why am I emailing now? To remind you that summer is over—and your news hiatus should be, too. We’re entering our second fall living with the coronavirus, Congress is gearing up to spend trillions of dollars, and the second-order effects of President Biden’s decisions in the Middle East are already coming to the fore. Sign up today for a full Dispatch membership, and we’ll do our best to guide you through a news landscape that is only growing crazier.

Unlike so many other media companies, we earn our money primarily from membership dues—not advertising. What does that mean in practice? We don’t write clickbait-y articles about things that don’t matter, because we don’t want you spending all day bouncing around our site. You’ll know everything you need to know to start your day after 10 or 15 minutes with our morning newsletter. We swim through the muck of national politics so that you don’t have to.

But The Morning Dispatch is far from the only benefit members receive in exchange for $100 per year. They have access to members-only David French columns on the intersection of politics, law, religion, and culture, as well as a midweek G-File from Jonah Goldberg about … well, whatever he feels like that day. Plus, Dispatch members have access to the most thoughtful comment section on the internet—and don’t just take my word for it. 

Our stable of writers is growing—and increasingly invaluable. Thomas Joscelyn, author of our Vital Interests national security newsletter, has been one of the smartest voices on Afghanistan for two decades, and Scott Lincicome’s weekly Capitolism newsletter has quickly become the go-to source for economic news and analysis for tens of thousands of readers. In the coming months, we plan to increase the frequency of our trademark Dispatch Lives—streamed conversations between our writers available only to members.

Now is a great time to consider upgrading your membership, and not just because the news cycle is picking up. This week only, we are offering a special 30-day free trial. Sign up now, and you get 13 months for the price of 12. If you decide it’s not for you at any point during those 30 days, you can cancel and pay nothing. But we hope you’ll stick with us.

A few weeks ago, member Tip Osterthaler commented on an edition of The Morning Dispatch to thank us for “staying true to [our] purpose” of “providing a source of factual information and reasoned commentary on important issues.”

“Just when I begin to think cable news and ideologically-aligned media have finally descended as far as they can go, I’m proven wrong,” he continued. “The Dispatch feels like an island of sanity in an increasingly chaotic world.”

We founded The Dispatch two years ago for people like Tip, who just want to cut through the noise and know what’s going on. Paying attention to the news in today’s climate is hard work, and finding information you can trust is even harder. Give us a chance, and we’ll do all we can to make it a little bit easier.

Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.